Knowing a patient's BRCA mutation status is important for prevention and treatment decision-making. Improving the characterization of mutations will lead to better management, treatment, and BCa prevention efforts in African Americans who are disproportionately affected with aggressive BCa and may inform future precision medicine genomic-based clinical studies.
No takes yet. Share an insight, caveat, or question.
Ricks‐Santi et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: